Rosalind Franklin University Helix 51 Incubator Company BLR Bio Presents Promising New Scleroderma Drug Data at International Rheumatology Meeting
PRNewsWire
·
2026-05-01
·
via The Tech Buzz - Press Releases
BLR-200 demonstrates unique mechanism blocking activation of scar-forming cells in systemic sclerosis models NORTH CHICAGO, Ill., April 30, 2026 /PRNewswire/ -- Rosalind Franklin University of Medicin
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。